The team built a multi-layered experimental framework combining dietary intervention, genetic edits in the ketogenic pathway, and targeted changes in lipid utilization. Their goal was to separate systemic ketogenesis from the local metabolic environment of the intestinal epithelium, an essential distinction because the gut rapidly processes dietary fats and nutrients.

They report that the KD consistently worsened outcomes: tumor burden increased and survival shortened. Importantly, this tumor acceleration occurred independently of circulating ketone metabolites. In other words, lowering insulin and boosting ketone production were not sufficient to explain the increased adenoma formation.

To probe causality, the investigators genetically manipulated 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 (HMGCS2), a key ketogenic enzyme. Whether they reduced or enhanced HMGCS2 activity, altering production of local and systemic ketone metabolites, the resulting changes did not translate into meaningful differences in intestinal tumorigenesis. The same held when they disrupted ketolysis, further dissociating ketone availability from cancer progression.

Attention then shifted from ketones to fatty acid utilization. When the study introduced intestinal loss of PPARα/δ/γ—transcriptional regulators that drive lipid-responsive gene programs—KD-driven expansion of intestinal stem cells declined. The researchers also observed reductions in proliferation and clonogenic growth, suggesting that KD’s tumor-promoting effects require lipid signaling that reshapes the stem-cell compartment.

Finally, the authors tested whether mitochondrial fatty acid oxidation is the downstream engine. By knocking out CPT1A, an essential gatekeeper for transporting long-chain fatty acids into mitochondria, they found a selective limitation of adenoma formation under KD conditions. This placed fatty acid oxidation of dietary lipids, rather than lipid accumulation or ketone metabolism, at the center of tumor initiation in this setting.

Overall, the work reframes ketogenic nutrition in cancer prevention terms: dietary lipid content can influence intestinal tumorigenesis through fatty acid oxidation pathways even when ketone metabolism is genetically uncoupled. For patients with genetically susceptible intestinal disease, these findings argue for a more nuanced evaluation of dietary strategies that may inadvertently feed oncogenic metabolic circuits.

Subject of Research:
Cancer metabolism; ketogenic diet; intestinal adenomas

Article Title:
Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones

Article References:
Shay, J.E.S., Chi, F., Tzouanas, C.N. et al. Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones. Nature (2026). https://doi.org/10.1038/s41586-026-10779-y

Image Credits:
AI Generated

DOI:
https://doi.org/10.1038/s41586-026-10779-y

Keywords:
ketogenic diet; intestinal cancer; fatty acid oxidation; HMGCS2; CPT1A; PPAR; ketones; stem cells; adenomas

The study, led by researchers at MIT, tested how a ketogenic regimen influences intestinal tumor development in animals predisposed to cancer. Mice received either a ketogenic diet, a standard control diet, or a high-fat/high-calorie diet, allowing the team to separate ketogenic effects from general fat overconsumption.

Results were striking in the small intestine: animals on the ketogenic diet developed significantly more tumors than those on control diets. In fact, tumor rates were similar to or even higher than those observed in the obesogenic high-fat/high-calorie group, despite the ketogenic group not becoming obese.

Mechanistically, the work challenges the idea that circulating ketone molecules are the main drivers. Additional experiments indicated that ketone bodies did not directly govern tumor formation; instead, tumor growth tracked with how intestinal cells metabolize dietary fat for energy.

That fat-burning pathway—fatty acid oxidation—activates PPAR-linked signaling, which increases stem cell proliferation in the intestinal lining. While such proliferation can help tissue repair after injury, the same “growth mode” appears to raise the probability that some proliferating cells transition toward malignancy.

The headline twist arrives when the researchers examine the colon. The ketogenic diet suppressed colon tumor development, echoing earlier reports that ketone-related metabolic shifts can be protective in this region.

Importantly, the new data suggest that colon protection is not mediated by ketone bodies. Rather, the same overall diet triggers opposing outcomes through region-dependent differences in lipid metabolism and stem cell behavior.

The findings carry a practical warning for the booming ketone-supplement market. Because the study attributes both risk and benefit to fat metabolism rather than ketones themselves, ketone drinks may not reproduce either the small-intestine danger or the colon protection observed in mice.

By highlighting how adjacent tissues respond differently to identical dietary inputs, the research suggests ketogenic therapies may need personalization—or at least careful monitoring—before they are broadly applied for cancer prevention or metabolic health.

Subject of Research: Animals (mouse models)
Article Title: Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones
News Publication Date: 15-Jul-2026
References: Nature (MIT study)
Keywords: ketogenic diet, intestinal cancer, fatty acid oxidation, PPAR signaling, stem cell proliferation, ketone bodies, colon tumors, small intestine tumors